Mismatch Repair-proficient Colorectal Cancer

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2025-01-28
Clinical Trial Update: Sequential Immunochemotherapy Treatment with Pembrolizumab Plus Dendritic Cell (DC) Vaccine Followed by Trifluridine/Tipiracil Plus Bevacizumab in Refractory Mismatch-repair-proficient (pMMR) or Microsatellite-stable (MSS) Metastatic Colorectal Cancer [Phase 2]
Phase 2 clinical trial of sequential immunochemotherapy in refractory metastatic colorectal cancer, starting with pembrolizumab plus a dendr…